SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001767
Filing Date
2021-09-10
Accepted
2021-09-10 16:31:12
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q inab-20210630.htm   iXBRL 10-Q 1993921
2 EX-31.1 inab-20210630ex31_1.htm EX-31.1 20941
3 EX-31.2 inab-20210630ex31_2.htm EX-31.2 20968
4 EX-32.1 inab-20210630ex32_1.htm EX-32.1 21701
5 GRAPHIC img237016903_0.jpg GRAPHIC 72903
  Complete submission text file 0000950170-21-001767.txt   6726790

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inab-20210630.xsd EX-101.SCH 42158
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inab-20210630_cal.xml EX-101.CAL 40336
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inab-20210630_def.xml EX-101.DEF 130260
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inab-20210630_lab.xml EX-101.LAB 375750
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inab-20210630_pre.xml EX-101.PRE 277814
11 EXTRACTED XBRL INSTANCE DOCUMENT inab-20210630_htm.xml XML 989614
Mailing Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016
Business Address 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY 10016 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39692 | Film No.: 211247394
SIC: 2836 Biological Products, (No Diagnostic Substances)